Table 4.
Safety Profile (Safety Set)
| Number (%) of Subjects Experiencing | Fasted (n=36) | Fed (n=36) |
|---|---|---|
| No AEs | 22 (61.1) | 22 (61.1) |
| One or more AEs | 14 (38.9) | 14 (38.9) |
| Pre-treatment AEs | 0 (0.0) | 0 (0.0) |
| One or more TEAEs | 14 (38.9) | 14 (38.9) |
| TEAE Severity | ||
| Mild | 13 (36.1) | 14 (38.9) |
| Moderate | 1 (2.8) | 0 (0.0) |
| Severe | 0 (0.0) | 0 (0.0) |
| TEAE Causality | ||
| Related | 12 (33.3) | 11 (30.6) |
| Not related | 2 (5.6) | 3 (8.3) |
| One or more TEAEs leading to drug withdrawal | 0 (0.0) | 0 (0.0) |
| One or more SAEs | 0 (0.0) | 0 (0.0) |
| SAE Causality | 0 (0.0) | 0 (0.0) |
| Related | 0 (0.0) | 0 (0.0) |
| Not related | 0 (0.0) | 0 (0.0) |
| Deaths | 0 (0.0) | 0 (0.0) |
Note: Values are shown as n (%).
Abbreviations: AE, adverse event; SAE, serious adverse event; TEAE, treatment-emergent adverse event.